DGAP-Adhoc: Manz AG receives confirmation for funding within the scope of the European Commission's IPCEI project 'EuBatIn - European Batteries Innovation'

Publication of inside information pursuant to Article 17 (1) of Regulation (EU) 596/2014 on market abuse (Market Abuse Regulation)

Manz AG receives confirmation for funding within the scope of the European Commission's IPCEI project "EuBatIn - European Batteries Innovation"

Reutlingen, January 26, 2021 - Manz AG, Reutlingen, (ISIN: DE000A0JQ5U3), was informed today that it has been granted substantial subsidies within the scope of the so-called IPCEI (Important Project of Common European Interest) "EuBatIn - European Batteries Innovation". The European Commission's funding, allocated for the establishment of a European Li-Ion battery production, will support the development of highly innovative and sustainable production technologies for lithium-ion battery cells and modules, which are characterized by a longer service life, shorter charging times, lower costs and a lower environmental impact compared to the current battery generation.

The amount of the funding that Manz AG will receive to realize the "Lithium-Ion Battery Factory of the Future" project has not yet been determined. Subject to final commitments to finance Manz AG's own contribution, the project is to be implemented by group companies in Germany and Italy. The project objective of the "Lithium Battery Factory of the Future" is to develop innovative production processes and the associated equipment based on a new, digitized and more cost-effective business model.

Additional information:

ISIN: DE000A0JQ5U3
Securities identification number: A0JQ5U
Stock exchange abbreviation: M5Z
Market segment: Regulated Market (Prime Standard) of the Frankfurt Stock Exchange

Manz AG
Steigäckerstraße 5
72768 Reutlingen
Germany

<end of ad hoc release>

Investor Relations Contact:

Manz AG
Axel Bartmann
Phone: +49 (0)7121 - 9000-395
Fax: +49 (0)7121 - 9000-99
E-Mail: [email protected]

cometis AG
Claudius Krause
Phone: +49 (0)611 - 205855-28
Fax: +49 (0)611 - 205855-66
E-Mail: [email protected]